Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Treatment Market Is Estimated To Witness High Growth Owing To Increasing Prevalence Of Cardiomyopathy
by The Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Treatment Market is estimated to be valued at US$ 2,980 Mn in 2027 and is expected to exhibit a CAGR …